Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men. (16th February 2022)

• Record Type: Journal Article
• Authors: Schumacher, Christina M; Thornton, Nicole; Wagner, Jessica; Tilchin, Carla; Ghanem, Khalil G; Hamill, Matthew M; Latkin, Carl; Rompalo, Anne; Ruhs, Sebastian; Greenbaum, Adena; Jennings, Jacky M
• Is Part Of: Clinical infectious diseases. Volume 75:Number 1(2022)
• Page Start: e1137
• Page End: e1144
• Publication Date: 2022-02-16
• Subjects: COVID-19 pandemic -- sexually transmitted infections -- MSM; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/ciab1053
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: Background: The impact of coronavirus disease 2019 (COVID-19) mitigation measures on sexually transmitted infection (STI) transmission and racial disparities remains unknown. Our objectives were to compare sex and drug risk behaviors, access to sexual health services, and STI positivity overall and by race during the COVID-19 pandemic compared with pre-pandemic among urban sexual minority men (MSM). Methods: Sexually active MSM aged 18–45 years were administered a behavioral survey and STI testing every 3-months. Participants who completed at least 1 during-pandemic (April 2020–December 2020) and 1 pre-pandemic study visit (before 13 March 2020) that occurred less than 6 months apart were included. Regression models were used to compare during- and pre-pandemic visit outcomes. Results: Overall, among 231 MSM, reports of more than 3 sex partners declined(pandemic-1: adjusted prevalence ratio 0.68; 95% confidence interval: .54–.86; pandemic-2: 0.65, .51–.84; pandemic-3: 0.57, .43–.75), substance use decreased (pandemic-1: 0.75, .61–.75; pandemic-2: 0.62, .50–.78; pandemic-3: 0.61, .47–.80), and human immunodeficiency virus/preexposure prophylaxis care engagement (pandemic-1: 1.20, 1.07–1.34; pandemic-2: 1.24, 1.11–1.39; pandemic-3: 1.30, 1.16–1.47) increased. STI testing decreased (pandemic-1: 0.68, .57–.81; pandemic-2: 0.78, .67–.92), then rebounded (pandemic-3: 1.01, .87–1.18). Nei­ther Chlamydia (pandemic-2: 1.62, .75–3.46; pandemic-3: 1.13, .24–1.27) nor gonorrhea (pandemic-2: 0.87, .46 1.62; pandemic-3: 0.56, .24–1.27) positivity significantly changed during vs pre-pandemic. Trends were mostly similar among Black vs. non-Black MSM. Conclusions: We observed sustained decreases in STI risk behaviors but minimal change in STI positivity during compared with pre-pandemic. Our findings underscore the need for novel STI prevention strategies that can be delivered without in-person interactions. Abstract : In a cohort study of men who have sex with men, sustained declines in sex and drug risk behaviors were reported during the coronavirus disease 2019 pandemic compared with pre-pandemic; however, chlamydia and gonorrhea positivity was similar during and pre-pandemic.